WebAug 15, 2024 · Chengdu Kanghong Biotech Co., Ltd. ClinicalTrials.gov Identifier: NCT03630952 Other Study ID Numbers: KHB-1802 : First Posted: August 15, 2024 Key Record Dates: Last Update Posted: June 23, 2024 Last Verified: June 2024 Individual Participant Data (IPD) Sharing Statement: ... WebGet the latest Chengdu Kanghong Pharma Grp Co Ltd (002773) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment ...
MONT INI - patentimages.storage.googleapis.com
WebJan 25, 2014 · Chengdu Kanghong Pharmaceutical Group Co Ltd is a pharmaceutical company. The company is engaged in the research and development, production, and sales of medicine, chemical medicine, and … WebMar 21, 2024 · 3 848. Free-Float. 29,6%. More Financials. Company. Chengdu Kanghong Pharmaceutical Group Co., Ltd is a China-based company principally engaged in the research, development, manufacture and distribution of Chinese patent medicines, chemical drugs and biological products. The Company’s main products include Conbercept … teams breakout room attendance report
CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD
WebCHENGDU KANGHONG BIOTECHNOLOGIES CO LTD has a total of 31 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in … WebDec 31, 2024 · CHENGDU KANGHONG PHARMACEUTICALS GROUP CO., LTD. Party Type 20 - Owner at Publication Legal Entity Type 99 - Other (Limited Company). Address Please log in with your Justia account to see this address. Party Name CHENGDU KANGHONG PHARMACEUTICALS GROUP CO., LTD. Party Type 10 - Original … WebChengdu Kanghong Biotech Co Ltd For information regarding COVID-19 clinical trials, please visit www.covid19studies.org or click here . Log In / Sign Up teams breakout